Header cover image

French Potential Opportunities

UPDATED Nov 27, 2023

Companies that are potentially undervalued based on future cash flows and market ratios.

137 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv YieldIndustry
FRVIAForvia€17.222.2%11.9%€3.4b€28.06PB0.8xE47.4%0%Automobiles
MDMMaisons du Monde€4.55-7.7%-60.8%€167.5m€7.90PE6.3xE3.0%6.6%Retail
INFInfotel€45.60-2.8%-15.6%€314.1m€55.34PE15.7xE6.3%4.4%Software
SFPIGROUPE SFPI€1.56-2.6%-29.3%€143.7m€3.80PE8.2xE25.1%3.2%Tech
RXLRexel€21.641.8%16.5%€6.5b€24.83PE7.3xE-3.1%5.5%Capital Goods
ALOAlstom€11.92-4.3%-51.5%€4.6b€22.03PB0.5xE89.3%2.1%Capital Goods
TFITF1€6.911.0%-4.1%€1.5b€9.89PE8.8xE15.4%7.2%Media
ALICAIcape Holding€10.00-8.3%-34.9%€80.9m€18.50PE9.4xE16.5%2.0%Tech
DBGDerichebourg€4.908.1%-3.9%€780.7m€7.92PE4.1xE5.3%6.5%Commercial Services
TKTTTarkett€9.160.9%-25.2%€599.4m€10.00PB0.7xS0.4%0%Capital Goods
ALTAAltarea€69.900.1%-49.9%€1.4b€80.00PB0.7xE63.6%14.3%Real Estate
ALMRBMr.Bricolage€8.101.0%-1.2%€82.9m€16.00PE4.2xE-0.4%0%Retail
VKVallourec€13.504.0%26.2%€3.1b€19.57PE6.6xE4.5%0%Energy
IPNIpsen€102.60-1.6%-5.7%€8.5b€127.95PE20.9xE13.1%1.2%Pharmaceuticals & Biotech
GBTGuerbet€18.805.6%11.5%€237.3m€19.08PB0.6xE101.1%2.7%Healthcare
ALVALValbiotis€5.54-5.1%50.5%€68.7m€11.83PS15.7xE73.6%n/aPharmaceuticals & Biotech
ALMOUMoulinvest€21.80-4.4%-39.7%€66.0m€40.00PE4.2xE-7.6%4.6%Materials
RUIRubis€22.160.9%-8.8%€2.3b€33.30PE8.7xE12.6%8.7%Utilities
ALVETTheraVet€1.61-1.2%-48.6%€5.2m€12.50PS4xE42.3%n/aPharmaceuticals & Biotech
TEPTeleperformance€128.95-2.5%-39.7%€7.7b€192.27PE11.9xE16.7%3.0%Commercial Services
ORAPOrapi€6.440.3%35.3%€42.0m€6.50PB0.8xE147.1%0%Materials
IDIPIDI€64.801.3%30.9%€453.6m€78.00PE3.6xE-16.3%3.9%Diversified Financials
SOPSopra Steria Group€189.400.5%31.1%€3.8b€236.26PE15.4xE16.9%2.3%Software
VCTVicat€32.00-0.8%37.3%€1.4b€34.86PE8.2xE7.6%5.2%Materials
Page 1 of 6